TITLE

Some HIV patients treated during early infection test negative

AUTHOR(S)
Iversen, John
PUB. DATE
July 2004
SOURCE
Bay Area Reporter;7/22/2004, Vol. 34 Issue 30, p19
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
Reports that some HIV patients who received antiretroviral therapy early after infection test negative for HIV. Findings by researchers from the San Francisco, California-based University of California; Implications for HIV care and treatment.
ACCESSION #
14029823

 

Related Articles

  • Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands. Hubben, Gijs A. A.; Bos, Jasper M.; Veltman-Starkenburg, Christa A.; Stegmeijer, Simon; Finnern, Henrik W.; Kappelhoff, Bregt S.; Simpson, Kit N.; Tramarin, Andrea; Postma, Maarten J. // Cost Effectiveness & Resource Allocation;2007, Vol. 5, p15 

    Background: This study compares the costs and effects of a regimen with ritonavir-boosted tipranavir (TPV/r) to a physician-selected genotypically-defined standard-of-care comparator protease inhibitor regimen boosted with ritonavir (CPI/r) in HIV infected patients that were previously exposed...

  • Five-Year Outcomes of the China National Free Antiretroviral Treatment Program.  // Annals of Internal Medicine;8/18/2009, Vol. 151 Issue 4, pI-42 

    The article presents a study on the rate of recovery of patients in the National Free Antiretroviral Treatment Program in China after five years. It notes that 48,785 patients with HIV were enrolled in the program under the highly active antiretroviral therapy. It mentions that after 6 months of...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Jan2001, Vol. 15 Issue 1, p53 

    Presents news updates on antiviral agents for HIV infections as of January 2001. Incidence of osteonecrosis of the hip among HIV patients; Potential complications of antiretroviral therapy for treating HIV infections; Commercial release of the antiretroviral agent didanosine by Bristol-Myers...

  • Barriers to and Facilitators of HIV-Positive Patients' Adherence to Antiretroviral Treatment... Roberts, Kathleen Johnston // AIDS Patient Care & STDs;Mar2000, Vol. 14 Issue 3, p155 

    Describes the barriers faced by HIV-positive patients in adhering to antiretroviral regimens and the strategies they use to maximize their adherence. Importance of better health education on the need for adherence; Need for simplified antiretroviral regimens; Primary facilitators of patients'...

  • Incidence of Resistance in a Double-Blind Study Comparing Lopinavir/Ritonavir Plus Stavudine and Lamivudine to Nelfinavir plus Stavudine and Lamivudine. Kempf, Dale J.; King, Martin S.; Bernstein, Barry; Cernohous, Paul; Bauer, Eric; Moseley, Jennifer; Kai Gu, Jennifer; Hsu, Ann; Brun, Scott; Sun, Eugene // Journal of Infectious Diseases;1/1/2004, Vol. 189 Issue 1, p51 

    Reports on the incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine in anteroretroviral therapy-naive human immunodeficiency virus (HIV) type 1-infected subjects. Study methods; Primary mutations...

  • Oral Glucose Loading for Detection of Mitochondrial Toxicity During HAART in HIV-Infected Patients. Ter Hofstede, Hadewych J. M.; Borm, George F.; Koopmans, Peter P. // Current HIV Research;Oct2007, Vol. 5 Issue 4, p389 

    Nucleoside reverse transcriptase inhibitors used in antiretroviral therapy may cause mitochondrial toxicity. Mitochondrial dysfunction leads to disturbance of the glucose metabolism, resulting in an accumulation of L-lactate. We tested the hypothesis that an oral glucose tolerance test (OGTT)...

  • Single Center experience with sides effects of "Triomune®" in Mali. Oumar, A. A.; Dao, S.; Malle, A.; Maiga, A. I.; Fongoro, S.; Diallo, A.; Yombi, J. C. // Journal of Antivirals & Antiretrovirals;2011, Vol. 3 Issue 4, p51 

    Objective: The main objective was to evaluate the sides effects of "Triomune®" among HIV patients followed at Hospital setting. Methods: Our study concerned 68 patients infected by the HIV under antiretroviral treatment with "Triomune®" in infectious diseases service of Point G hospital...

  • Adherence to Antiretroviral Therapy: How Much Is Enough? Gulick, Roy M. // Clinical Infectious Diseases;10/1/2006, Vol. 43 Issue 7, p942 

    The article presents a study on the efficiency of the antiretroviral therapy. It has been stated that the development of effective antiretroviral therapy in the resulted to significant virologic suppression and immune reconstitution and resulted in dramatic reductions in HIV-related morbidity...

  • "BUILDING THE FUTURE ON PAST REMAINS" -- CASE PRESENTATION OF HIV MULTIEXPERIENCED PATIENT. Munteanu, Daniela Ioana; Mihailescu, Raluca; Cercel, Anca Streinu; Aramă, Victoria // Therapeutics, Pharmacology & Clinical Toxicology;2011, Vol. 15 Issue 1, p62 

    Introduction - HAART history is a history of changes, each new antiretroviral combination represents a chance to obtain viral undetectability. Objective - case presentation of HIV multiexperienced patient with virological failure, which belongs to the Romanian cohort of children and adolescents...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics